Bharat Book Bureau Provides the Trending Market Research Report on “Bioelectronic Medicine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented by Type (Implantable v/s Non-invasive), By Product (Implantable Cardioverter Defibrillators, Cardiac pacemakers, Cochlear implants, Spinal cord stimulators, Deep Brain Stimulators, Transcutaneous Electrical Nerve Stimulators, Sacral Nerve Stimulators, Vagus Nerve stimulators, Others), By Application (Arrhythmia, Pain Management, Sensorineural Hearing loss, Parkinson’s disease, Tremor, Depression, Treatment-resistant depression, Epilepsy, Urinary and Fecal Incontinence, Others), By End User (Hospitals, Individual Users, Homecare Centers, Ambulatory Surgical Centers, Specialty Clinics, Others), By Region and Competition” under the Life Sciences Market Research Report Category. The report offers a collection of superior Market research, Market analysis, competitive intelligence, and Market reports.
Global Bioelectronic Medicine Market is anticipated to register a steady CAGR during the forecast period 2024-2028. This can be ascribed to the increasing demand for advanced healthcare products for the treatment of chronic disorders such as cardiovascular diseases and neurological disorders. Additionally, growing initiatives and investments by government organizations for developing new bioelectronic medicine have significantly increased the demand for the bioelectronic medicine market across different parts of the globe. Additionally, the growing adoption of new technology in the healthcare sector has significantly increased, and increasing awareness about using new medicine such as pacemakers and defibrillators and the benefits of using these devices is further expected to increase the demand for the bioelectronic device, thereby fuelling the market growth through 2028. Furthermore, increasing the number of major key players in the market focus on developing new technology for the benefit of users is further expected to increase the demand for the bioelectronic device, thereby supporting market growth.
Growing Prevalence of Cardiovascular and Neurological Disorders
The increasing number of people suffering from various types of chronic diseases, such as cardiovascular diseases and neurological disorders, is expected to enhance the demand for the bioelectric medicine market during the forecast period. According to the Centers for Disease Control and Prevention, heart diseases are the main cause of death in the United States, one person dies every 34 seconds, and about 697,000 people die because of heart disease in the United States, which is equal to 1 in every five deaths. So, the growth of this population group will ensure that the need for the treatment of cardiovascular and neurological problems will expand over the years. Due to high blood pressure, high low-density lipoprotein cholesterol, diabetes, smoking, secondhanded smoke exposure, obesity, unhealthy diet, and physical inactivity increase the number of cardiovascular diseases, which is expected to enhance the demand for bioelectronic medicine during the forecast period.
Technological Advancements
The growing development of medical devices that help to target specific nerve fibers or brain circuits to treat different types of medical ailments can boost the market growth during the forecast period. It is used to diagnose and treat different types of chronic diseases, such as Parkinson’s disease, major depressive disorder, and chronic pain. Technological innovations are making devices smaller and less invasive, along with companies bringing new applications into the market during the forecast period. Different type of bioelectronic medicine is available for the treatment of chronic diseases, such as a pacemaker and defibrillator so, which can reduce pain. This type of therapy can be used in the method of spinal cord stimulation and implantation, such as for the cochlea and retina. For instance, electroconvulsive therapies are used for the treatment of major chronic disorders, and this device-controlled electrical stimulation triggers a brief seizure which affects neurons in the brain.
In January 2021, Boston Scientific Corporation, a U.S.-based manufacturer of medical devices, received authorization from the U.S. FDA for fourth generation Vercise Genus Deep Brain Stimulation (DBS) System. This device is equipped with Bluetooth enabled and rechargeable or non-rechargeable, preference by doctor and patient. It can be helpful for the treatment of Parkinson’s disease by providing electrical impulses which lead to the brain and is connected to Implantable Pulse Generator.
Market Segmentation
The global bioelectronic medicine market can be segmented by type, product, application, end-user, and by region. Based on type, the market can be divided into implantable v/s non-invasive. Based on product, the market can be segmented into implantable cardioverter defibrillators, cardiac pacemakers, cochlear implants, spinal cord stimulators, deep brain stimulators, transcutaneous electrical nerve stimulators, sacral nerve stimulators, vagus nerve stimulators, and others. Based on application, the market can be differentiated into arrhythmia, pain management, sensorineural hearing loss, Parkinson’s disease, tremors, depression, treatment-resistant depression, epilepsy, urinary and fecal incontinence, and others. Based on end-user, the market is split into hospitals, individual users, homecare centers, ambulatory surgical centers, specialty clinics, and others. On the basis of region, the market is divided into North America, Asia Pacific, Europe, Middle East & Africa, and South America, among which North America dominated the market. On the basis of country, the United States dominated the global bioelectronic medicine market on account of the increasing geriatric population along with an increase in the frequency of neurological and cardiovascular disorder problems in the country.
Market Players
Medtronic plc., Abbott Laboratories, Inc., Boston Scientific Corporation., Cochlear Ltd., LivaNova PLC., Soterix Medical Inc., Bioinduction Ltd., GiMer Medical., Cefaly., BioControl Medical. are some of the leading players operating in the Global Bioelectronic Medicine Market.
Report Scope:
In this report, the global bioelectronic medicine market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:
•Bioelectronic Medicine Market, By Type:
oImplantable
oNon-invasive
•Bioelectronic Medicine Market, By Product:
oImplantable cardioverter defibrillators
oCardiac pacemakers
oCochlear implants
oSpinal cord stimulators
oDeep brain stimulators
oTranscutaneous electrical nerve stimulators
oSacral nerve stimulators
oVagus nerve stimulators
oOthers
•Bioelectronic Medicine Market, By Application:
oArrhythmia
oPain management
oSensorineural hearing loss
oParkinson’s disease
oTremor
oDepression
oTreatment-resistant depression
oEpilepsy
oUrinary and fecal incontinence
oOthers
•Bioelectronic Medicine Market, By End User:
oHospitals
oIndividual Users
oHomecare Centers
oAmbulatory Surgical Centers
oSpecialty Clinics
oOthers
•Bioelectronic Medicine Market, By Region:
oNorth America
§United States
§Canada
§Mexico
oEurope
§France
§Germany
§United Kingdom
§Italy
§Spain
oAsia Pacific
§China
§India
§Japan
§South Korea
§Australia
oSouth America
§Brazil
§Argentina
§Colombia
oMiddle East & Africa
§South Africa
§Saudi Arabia
§UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Bioelectronic Medicine Market.
Available Customizations:
With the given market data, offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
•Detailed analysis and profiling of additional market players (up to five).
Browse our full report with Table of Content:
About Bharat Book Bureau:
Bharat Book is Your One-Stop-Shop with an exhaustive coverage of 4,00,000 reports and insights that includes latest Market Study, Market Trends & Analysis, Forecasts Customized Intelligence, Newsletters and Online Databases. Overall a comprehensive coverage of major industries with a further segmentation of 100+ subsectors.
Contact us at:
Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Email: [email protected]
Website: www.bharatbook.com
Tadarise 40 mg of medicine is a very good option for men to get rid of a disease called erectile dysfunction from the body.
There are many medicines available in the market today to cure the disease called erectile dysfunction.
But in all of this, Tadarise 40 mg medicine is very good and effective medicine.
There are many dosages of 50 mg of medicine available at the medypharmacy such as Tadarise, Tadarise 20 mg, Tadarise 60 mg.
There are lots of third party manufacturing pharma companies out there in the Indian market which are providing quality manufacturing service for medicine.
All the listed Third Party Pharma Manufacturers prepared medicines as per the WHO and GMP standard norms.
